Baxter Bros Inc Abb Vie Inc. Transaction History

Baxter Bros Inc

$762 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $21,691 - $24,981	-150 Reduced 10.03%	1,345 $214,000
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $87,236 - $100,054	-650 Reduced 30.3%	1,495 $201,000
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $933,614 - $1.19 Million	-6,784 Reduced 75.98%	2,145 $329,000
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $78,924 - $97,922	-598 Reduced 6.28%	8,929 $1.45 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $57,260 - $72,450	533 Added 5.93%	9,527 $1.29 Million
Q3 2021 Oct 25, 2021	BUY	$106.4 - $120.78 $22,556 - $25,605	212 Added 2.41%	8,994 $970,000
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $22,409 - $24,965	-213 Reduced 2.37%	8,782 $989,000
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $112,836 - $124,219	1,103 Added 13.98%	8,995 $973,000
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $234,386 - $316,447	2,912 Added 58.47%	7,892 $846,000
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $34,535 - $40,533	-402 Reduced 7.47%	4,980 $436,000
Q4 2019 Jan 09, 2020	BUY	$72.13 - $90.25 $388,203 - $485,725	5,382 New	5,382 $352,000
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $176,281 - $211,940	-2,799 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $3,285 - $4,199	50 Added 1.82%	2,799 $204,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $19,285 - $22,697	-250 Reduced 8.34%	2,749 $222,000
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $62,279 - $76,808	800 Added 36.38%	2,999 $276,000
Q3 2018 Oct 11, 2018	SELL	$88.91 - $98.84 $75,573 - $84,014	-850 Reduced 27.88%	2,199 $208,000
Q1 2018 May 16, 2018	BUY	$92.01 - $123.21 $46,005 - $61,605	500 Added 19.62%	3,049 $289,000
Q4 2017 Feb 01, 2018	BUY	$89.56 - $98.21 $4,478 - $4,910	50 Added 2.0%	2,549 $247,000
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $174,555 - $222,960	2,499	2,499 $222,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account